AIMS: The impact of a high-fat diet on the failing heart is unclear, and the differences between polyunsaturated fatty acids (PUFA) and saturated fat have not been assessed. Here, we compared a standard low-fat diet to high-fat diets enriched with either saturated fat (palmitate and stearate) or PUFA (linoleic and α-linolenic acids) in hamsters with genetic cardiomyopathy. METHODS AND RESULTS: Male δ-sarcoglycan null Bio TO2 hamsters were fed a standard low-fat diet (12% energy from fat), or high-fat diets (45% fat) comprised of either saturated fat or PUFA. The median survival was increased by the high saturated fat diet (P< 0.01; 278 days with standard diet and 361 days with high saturated fat)), but not with high PUFA (260 days) (n = 30-35/group). Body mass was modestly elevated (∼10%) in both high fat groups. Subgroups evaluated after 24 weeks had similar left ventricular chamber size, function, and mass. Mitochondrial oxidative enzyme activity and the yield of interfibrillar mitochondria (IFM) were decreased to a similar extent in all TO2 groups compared with normal F1B hamsters. Ca(2+)-induced mitochondrial permeability transition pore opening was enhanced in IFM in all TO2 groups compared with F1B hamsters, but to a significantly greater extent in those fed the high PUFA diet compared with the standard or high saturated fat diet. CONCLUSION: These results show that a high intake of saturated fat improves survival in heart failure compared with a high PUFA diet or low-fat diet, despite persistent mitochondrial defects.
AIMS: The impact of a high-fat diet on the failing heart is unclear, and the differences between polyunsaturated fatty acids (PUFA) and saturated fat have not been assessed. Here, we compared a standard low-fat diet to high-fat diets enriched with either saturated fat (palmitate and stearate) or PUFA (linoleic and α-linolenic acids) in hamsters with genetic cardiomyopathy. METHODS AND RESULTS: Male δ-sarcoglycan null Bio TO2 hamsters were fed a standard low-fat diet (12% energy from fat), or high-fat diets (45% fat) comprised of either saturated fat or PUFA. The median survival was increased by the high saturated fat diet (P< 0.01; 278 days with standard diet and 361 days with high saturated fat)), but not with high PUFA (260 days) (n = 30-35/group). Body mass was modestly elevated (∼10%) in both high fat groups. Subgroups evaluated after 24 weeks had similar left ventricular chamber size, function, and mass. Mitochondrial oxidative enzyme activity and the yield of interfibrillar mitochondria (IFM) were decreased to a similar extent in all TO2 groups compared with normal F1B hamsters. Ca(2+)-induced mitochondrial permeability transition pore opening was enhanced in IFM in all TO2 groups compared with F1B hamsters, but to a significantly greater extent in those fed the high PUFA diet compared with the standard or high saturated fat diet. CONCLUSION: These results show that a high intake of saturated fat improves survival in heart failure compared with a high PUFA diet or low-fat diet, despite persistent mitochondrial defects.
Authors: Monika K Duda; Karen M O'Shea; Biao Lei; Brian R Barrows; Agnes M Azimzadeh; Tracy E McElfresh; Brian D Hoit; Willem J Kop; William C Stanley Journal: J Card Fail Date: 2008-05 Impact factor: 5.712
Authors: Isidore C Okere; Martin E Young; Tracy A McElfresh; David J Chess; Victor G Sharov; Hani N Sabbah; Brian D Hoit; Paul Ernsberger; Margaret P Chandler; William C Stanley Journal: Hypertension Date: 2006-10-23 Impact factor: 10.190
Authors: Giovan Giuseppe Mattera; Pietro Lo Giudice; Francesca M P Loi; Emilio Vanoli; Jean-Pierre Gagnol; Franco Borsini; Paolo Carminati Journal: Am J Cardiol Date: 2006-09-18 Impact factor: 2.778
Authors: Thomas L Halton; Walter C Willett; Simin Liu; JoAnn E Manson; Christine M Albert; Kathryn Rexrode; Frank B Hu Journal: N Engl J Med Date: 2006-11-09 Impact factor: 91.245
Authors: Adam J Chicco; Genevieve C Sparagna; Sylvia A McCune; Christopher A Johnson; Robert C Murphy; David A Bolden; Meredith L Rees; Ryan T Gardner; Russell L Moore Journal: Hypertension Date: 2008-07-28 Impact factor: 10.190
Authors: Julie H Rennison; Tracy A McElfresh; Isidore C Okere; Hiral V Patel; Amy B Foster; Kalpana K Patel; Maria S Stoll; Paul E Minkler; Hisashi Fujioka; Brian D Hoit; Martin E Young; Charles L Hoppel; Margaret P Chandler Journal: Cardiovasc Res Date: 2008-03-13 Impact factor: 10.787
Authors: Naveen Sharma; Isidore C Okere; Brian R Barrows; Biao Lei; Monika K Duda; Celvie L Yuan; Stephen F Previs; Victor G Sharov; Agnes M Azimzadeh; Paul Ernsberger; Brian D Hoit; Hani Sabbah; William C Stanley Journal: J Hypertens Date: 2008-07 Impact factor: 4.844
Authors: Olesya Ilkun; Nicole Wilde; Joseph Tuinei; Karla M P Pires; Yi Zhu; Heiko Bugger; Jamie Soto; Benjamin Wayment; Curtis Olsen; Sheldon E Litwin; E Dale Abel Journal: J Mol Cell Cardiol Date: 2015-05-22 Impact factor: 5.000
Authors: Girma Asemu; Kelly A O'Connell; James W Cox; Erinne R Dabkowski; Wenhong Xu; Rogerio F Ribeiro; Kadambari C Shekar; Peter A Hecker; Sharad Rastogi; Hani N Sabbah; Charles L Hoppel; William C Stanley Journal: Am J Physiol Heart Circ Physiol Date: 2012-12-15 Impact factor: 4.733
Authors: Erinne R Dabkowski; Kelly A O'Connell; Wenhong Xu; Rogerio F Ribeiro; Peter A Hecker; Kadambari Chandra Shekar; Caroline Daneault; Christine Des Rosiers; William C Stanley Journal: Cardiovasc Drugs Ther Date: 2013-12 Impact factor: 3.727
Authors: Elizabeth F Lopez; Janusz H Kabarowski; Kevin A Ingle; Vasundhara Kain; Stephen Barnes; David K Crossman; Merry L Lindsey; Ganesh V Halade Journal: Am J Physiol Heart Circ Physiol Date: 2014-12-05 Impact factor: 4.733
Authors: Oluwabunmi A Tokede; Andrew B Petrone; Naomi Q Hanson; Michael Y Tsai; Natalie A Weir; Robert J Glynn; J Michael Gaziano; Luc Djoussé Journal: Am J Clin Nutr Date: 2013-02-27 Impact factor: 7.045
Authors: Kadambari Chandra Shekar; Ling Li; Erinne R Dabkowski; Wenhong Xu; Rogerio Faustino Ribeiro; Peter A Hecker; Fabio A Recchia; Rovshan G Sadygov; Belinda Willard; Takhar Kasumov; William C Stanley Journal: J Mol Cell Cardiol Date: 2014-07-01 Impact factor: 5.000